The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Centers for Medicare and Medicaid (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

The Trump administration Friday discarded a proposal made in the last months of the Biden presidency that would have expanded coverage of anti-obesity drugs to an estimated 7.5 million people covered ...

But so far, though, the jury is still out on whether anti-obesity drugs and specifically the GLP-1 therapies positively impact overall healthcare costs. “Currently, there is scant GLP-1 weight loss ...

Food companies have began discussing changes the drugs will bring, as well as new marketing strategies within the dairy industry. Fereday spoke about anti-obesity drugs and diet implications at the ...

If you have a modest income, are struggling with your weight and eyeballing the health benefits of obesity medications, we have to be honest that the reality of how these drugs might affect your ...

The House Ways and Means Committee in the US voted in favour of a new bill which would end a two-decade-long restriction on the coverage of drugs to treat obesity under Medicare. The Treat and ...